Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this month.

FDA’s Aduhelm Approval Process was Problematic

Biogen was prepared to spend more than two-and-a-half times the cost of the drug’s development on marketing.

Download
Getty Images

According to a recent New York Times article, a congressional investigation into the FDA’s approval of Alzheimer’s drug Aduhelm was “rife with irregularities.” The 18-month investigation was initiated by two congressional committees after the drug was approved. The review determined that Biogen, the drug’s manufacturer, set “an unjustifiably high price” of $56k/year in an effort to make history and “establish Aduhelm as one of the top pharmaceutical launches of all time.” The investigation also revealed that Biogen budgeted several billion dollars to aggressively market and counter anticipated pushback against critics of its price. 

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO